Is Teva Pharmaceutical Industries Ltd. FDA approved?

Teva Pharmaceutical Industries Ltd. holds 6 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Teva Pharmaceutical Industries Ltd.'s drugs manufactured?

At registered sites in Canada, Germany, Israel, the United States. The FDA register lists Markham; Scarborough; Stouffville; Ulm; Kfar Saba; Fairfield, NJ. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.

What drugs does Teva Pharmaceutical Industries Ltd. make?

668 products are listed under Teva Pharmaceutical Industries Ltd. in the openFDA NDC Directory, most often as tablet, film coated; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Are any Teva Pharmaceutical Industries Ltd. products in shortage?

44 presentations are currently listed in the FDA drug shortage database under Teva Pharmaceutical Industries Ltd., covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet, Azacitidine Injection, Carboplatin Injection and 7 other drugs.

Teva Pharmaceutical Industries Ltd.

Data as of 1 Oct 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 6
Active NDC listings: 651
Labeller names: 5
Live patents: 119
Shortage listings: 97
Countries: 4
Base: Canada

Authorisation

Registered operations

Analytical testing6Active ingredient (API) manufacture1Labelling4Finished drug manufacture4Packaging4sterilize1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Teva Canada Limited	575 Hood Rd., Markham, Ontario L3R4E1, Canada (CAN)	Analytical testing, Labelling, Finished drug manufacture, Packaging	3002807742207021015
Teva Canada Limited	30 Novopharm Court, Scarborough, Ontario M1B2K9, Canada (CAN)	Analytical testing, Labelling, Packaging	3002807756201518008
Teva Canada Limited	5691 Main St., Stouffville, Ontario L4A1H5, Canada (CAN)	Analytical testing, Finished drug manufacture	3002807750253219422
Teva Biotech GmbH	Dornierstrasse 10, Ulm, 89079, Germany (DEU)	Analytical testing, Active ingredient (API) manufacture	3007817154333736655
Teva Pharmaceutical Industries Ltd.	18 Eli Hurvitz Street, Industrial Zone, Kfar Saba, 4410202, Israel (ISR)	Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize	3002721084533065814
Teva Pharmaceuticals USA, Inc.Registrant: Teva Pharmaceuticals USA Inc.	8-10 Gloria Lane, Fairfield, New Jersey (NJ) 07004-3306, United States (USA)	Analytical testing, Labelling, Finished drug manufacture, Packaging	2245641614039840

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)	Current	Limited Availability	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)	Current	Available	12 Oct 20221 Oct 2026
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry	Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)	Current	Unavailable	12 Oct 20221 Oct 2026
Azacitidine InjectionOncology	Azacitidine, Injection, 100 mg (NDC 68001-313-56)	Current	Unavailable	22 Dec 20201 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)	Current	Unavailable	28 Apr 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)	Current	Limited Availability	28 Apr 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)	Current	Limited Availability	28 Apr 20231 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, .5 mg (NDC 0093-0832-05)	Current	Available	10 Mar 20231 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)	Current	Available	10 Mar 20231 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, 1 mg (NDC 0093-3212-05)	Current	Available	10 Mar 20231 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, 2 mg (NDC 0093-3213-01)	Current	Available	10 Mar 20231 Oct 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, 2 mg (NDC 0093-3213-05)	Current	Available	10 Mar 20231 Oct 2026
Hydromorphone Hydrochloride InjectionAnalgesia/Addiction	Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)	Current	Limited Availability	1 Nov 20171 Oct 2026
Hydromorphone Hydrochloride InjectionAnalgesia/Addiction	Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)	Current	Available	1 Nov 20171 Oct 2026
Hydromorphone Hydrochloride InjectionAnalgesia/Addiction	Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)	Current	Available	1 Nov 20171 Oct 2026
Hydroxocobalamin InjectionOther	Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)	Current	Unavailable	4 Nov 20241 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)	Current	Available	14 Jul 20231 Oct 2026
Lisdexamfetamine Dimesylate CapsulePsychiatry	Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)	Current	Available	14 Jul 20231 Oct 2026
Methotrexate Sodium InjectionRheumatology, Oncology	Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)	Current	Limited Availability	13 Mar 20231 Oct 2026
Methotrexate Sodium InjectionRheumatology, Oncology	Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)	Current	Limited Availability	13 Mar 20231 Oct 2026
Methotrexate Sodium InjectionRheumatology, Oncology	Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)	Current	Limited Availability	13 Mar 20231 Oct 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)	Current	Available	26 Jul 20231 Oct 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)	Current	Available	26 Jul 20231 Oct 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)	Current	Limited Availability	26 Jul 20231 Oct 2026
Methylphenidate Hydrochloride Tablet, Extended ReleasePsychiatry	Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)	Current	Limited Availability	26 Jul 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)	Current	Limited Availability	28 Apr 202315 Sept 2026
Streptozocin Powder, For SolutionOncology	Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)	Current	Unavailable	12 Jul 202215 Sept 2026
Clonazepam TabletNeurology, Pediatric, Psychiatry	Clonazepam, Tablet, 1 mg (NDC 0093-3212-01)	Current	Limited Availability	10 Mar 202317 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Metoprolol Succinate Tablet, Extended ReleaseCardiovascular	Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)	To Be Discontinued	-	31 Aug 202631 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Diclofenac Sodium Tablet, Delayed ReleaseMusculoskeletal, Rheumatology	Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11)	To Be Discontinued	-	13 Aug 202613 Aug 2026
Doxycycline Hyclate Tablet, Delayed ReleaseAnti-Infective	Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)	To Be Discontinued	-	30 Jul 202630 Jul 2026
Doxycycline Hyclate Tablet, Delayed ReleaseAnti-Infective	Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)	To Be Discontinued	-	30 Jul 202630 Jul 2026
Liraglutide InjectionEndocrinology/Metabolism	Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)	To Be Discontinued	-	14 May 202614 May 2026
Tiagabine Hydrochloride TabletNeurology	Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)	To Be Discontinued	-	15 Apr 202615 Apr 2026
Tiagabine Hydrochloride TabletNeurology	Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)	To Be Discontinued	-	15 Apr 202615 Apr 2026
Tiagabine Hydrochloride TabletNeurology	Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)	To Be Discontinued	-	15 Apr 202615 Apr 2026
Tiagabine Hydrochloride TabletNeurology	Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)	To Be Discontinued	-	15 Apr 202615 Apr 2026
Everolimus TabletTransplant	Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)	To Be Discontinued	-	2 Mar 20262 Mar 2026
Everolimus TabletTransplant	Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)	To Be Discontinued	-	2 Mar 20262 Mar 2026
Everolimus TabletTransplant	Everolimus, Tablet, 10 mg (NDC 0093-7769-24)	To Be Discontinued	-	2 Mar 20262 Mar 2026
Everolimus TabletTransplant	Everolimus, Tablet, 5 mg (NDC 0093-7767-24)	To Be Discontinued	-	2 Mar 20262 Mar 2026
Allopurinol TabletOncology, Renal, Rheumatology	Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)	To Be Discontinued	-	19 Feb 202619 Feb 2026
Allopurinol TabletOncology, Renal, Rheumatology	Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)	To Be Discontinued	-	19 Feb 202619 Feb 2026
Allopurinol TabletOncology, Renal, Rheumatology	Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)	To Be Discontinued	-	19 Feb 202619 Feb 2026
Allopurinol TabletOncology, Renal, Rheumatology	Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)	To Be Discontinued	-	19 Feb 202619 Feb 2026
Hydroxychloroquine Sulfate TabletAnti-Infective, Other, Rheumatology	Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01)	To Be Discontinued	-	5 Jan 20265 Jan 2026
Calcitriol CapsuleEndocrinology/Metabolism	Calcitriol, Capsule, .25 ug (NDC 0093-7352-01)	To Be Discontinued	-	4 Dec 20254 Dec 2025
Calcitriol CapsuleEndocrinology/Metabolism	Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)	To Be Discontinued	-	4 Dec 20254 Dec 2025
Potassium Chloride Tablet, Extended ReleaseEndocrinology/Metabolism, Gastroenterology	Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01)	To Be Discontinued	-	21 Nov 202521 Nov 2025
Potassium Chloride Tablet, Extended ReleaseEndocrinology/Metabolism, Gastroenterology	Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10)	To Be Discontinued	-	21 Nov 202521 Nov 2025
Potassium Chloride Tablet, Extended ReleaseEndocrinology/Metabolism, Gastroenterology	Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)	To Be Discontinued	-	21 Nov 202521 Nov 2025
Potassium Chloride Tablet, Extended ReleaseEndocrinology/Metabolism, Gastroenterology	Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01)	To Be Discontinued	-	21 Nov 202521 Nov 2025
Anagrelide Hydrochloride CapsuleHematology	Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)	To Be Discontinued	-	19 Nov 202519 Nov 2025
Anagrelide Hydrochloride CapsuleHematology	Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)	To Be Discontinued	-	19 Nov 202519 Nov 2025
Hydrochlorothiazide CapsuleCardiovascular	Microzide, Capsule, 12.5 mg (NDC 0591-0347-05)	To Be Discontinued	-	19 Nov 202519 Nov 2025
Hydrochlorothiazide CapsuleCardiovascular	Microzide, Capsule, 12.5 mg (NDC 0591-0347-01)	To Be Discontinued	-	19 Nov 202519 Nov 2025
Palonosetron Hydrochloride InjectionGastroenterology	Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)	To Be Discontinued	-	14 Nov 202514 Nov 2025
Adalimumab-ryvk KitRheumatology	Simlandi, Kit, Kit (NDC 51759-523-21)	To Be Discontinued	-	13 Nov 202513 Nov 2025
Cetrorelix Acetate InjectionReproductive	Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)	To Be Discontinued	-	13 Nov 202513 Nov 2025
Tranylcypromine Sulfate TabletPsychiatry	Parnate, Tablet, 10 mg (NDC 0591-5590-01)	To Be Discontinued	-	21 Oct 202521 Oct 2025
Homatropine Methylbromide and Hydrocodone Bitartrate SyrupAnalgesia/Addiction	Hydromet, Syrup, 1.5 mg/5 mL; 5 mg/5 mL (NDC 0472-1030-16)	To Be Discontinued	-	11 Sept 202511 Sept 2025
Finasteride TabletUrology	Finasteride, Tablet, 5 mg (NDC 0093-7355-98)	To Be Discontinued	-	19 Aug 202519 Aug 2025
Finasteride TabletUrology	Finasteride, Tablet, 5 mg (NDC 0093-7355-56)	To Be Discontinued	-	19 Aug 202519 Aug 2025
Finasteride TabletUrology	Finasteride, Tablet, 5 mg (NDC 0093-7355-05)	To Be Discontinued	-	19 Aug 202519 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 200 mg (NDC 0591-3984-01)	To Be Discontinued	-	15 Aug 202515 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 100 mg (NDC 0591-3983-05)	To Be Discontinued	-	15 Aug 202515 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 100 mg (NDC 0591-3983-01)	To Be Discontinued	-	15 Aug 202515 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 50 mg (NDC 0591-3982-60)	To Be Discontinued	-	15 Aug 202515 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 200 mg (NDC 0591-3984-05)	To Be Discontinued	-	15 Aug 202515 Aug 2025
Celecoxib CapsuleAnalgesia/Addiction	Celecoxib, Capsule, 400 mg (NDC 0591-3985-60)	To Be Discontinued	-	15 Aug 202515 Aug 2025

Catalogue

Drug listings by form and route

651

651 active NDC listings: 611 human prescription drug, 39 drug for further processing, 1 human otc drug. By marketing category: ANDA 545, DRUG FOR FURTHER PROCESSING 39, NDA AUTHORIZED GENERIC 30, BLA 19, NDA 17.

Dosage form	NDCs
tablet, film coated	165
tablet	161
capsule	86
kit	50
capsule, extended release	31
tablet, orally disintegrating	20
powder, for suspension	13
capsule, liquid filled	12
injection, solution	12
tablet, chewable	11
cream	8
solution	8
tablet, film coated, extended release	8
injection	7
injection, suspension, extended release	7

Route	NDCs
oral	494
subcutaneous	22
respiratory (inhalation)	17
topical	12
intravenous	8
transdermal	5
intramuscular	4
vaginal	3
nasal	2
intrabronchial	1
ophthalmic	1

Labeller name on the listing	NDCs
teva pharmaceuticals usa, inc.	487
teva pharmaceuticals, inc.	159
teva pharmaceuticals usa inc	3
teva pharmaceuticals usa inc.	1
teva pharmaceuticals, inc.	1

Exclusivity

Patents and exclusivities

119

Patent	Product	Covers	Expiry
6987103	SYNRIBOomacetaxine mepesuccinate	use	Oct 2026
10195375	AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, ARMONAIR RESPICLICKfluticasone propionate; fluticasone propionate; salmeterol xinafoate	product	Feb 2031
10195375*PED	AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, ARMONAIR RESPICLICKfluticasone propionate; fluticasone propionate; salmeterol xinafoate	use	Aug 2031
9066957	AIRDUO DIGIHALER, AIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoate	product	Oct 2034
9415008	AIRDUO DIGIHALER, AIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoate	product	Oct 2034
9066957*PED	AIRDUO DIGIHALER, AIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoate	use	Apr 2035
9415008*PED	AIRDUO DIGIHALER, AIRDUO RESPICLICKfluticasone propionate; salmeterol xinafoate	use	Apr 2035
10918816	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	product	Dec 2035
10918816*PED	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	use	Jun 2036
11072586	ALVAIZeltrombopag choline	substance, product	Nov 2038
11969544	AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, ARMONAIR RESPICLICKfluticasone propionate; fluticasone propionate; salmeterol xinafoate	product	Aug 2039
11344685	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	product	Sept 2039
11969544*PED	AIRDUO DIGIHALER, AIRDUO RESPICLICK, ARMONAIR DIGIHALER, ARMONAIR RESPICLICKfluticasone propionate; fluticasone propionate; salmeterol xinafoate	use	Feb 2040
11344685*PED	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	use	Mar 2040
11173259	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	product	Jul 2040
11173259*PED	AIRDUO DIGIHALER, ARMONAIR DIGIHALERfluticasone propionate; fluticasone propionate; salmeterol xinafoate	use	Jan 2041

Catalogue

Marketed products

668

Showing 150 of 668.

Brand	Generic name	Form / route	NDC
AJOVY	fremanezumab-vfrm	injection, subcutaneous	51759-202BLA
AJOVY	fremanezumab-vfrm	injection, subcutaneous	51759-204BLA
ALVAIZ	Eltrombopag	tablet, film coated, oral	0480-3273NDA
ALVAIZ	Eltrombopag	tablet, film coated, oral	0480-3274NDA
ALVAIZ	Eltrombopag	tablet, film coated, oral	0480-3275NDA
ALVAIZ	Eltrombopag	tablet, film coated, oral	0480-3276NDA
ALYQ	Tadalafil	tablet, film coated, oral	0480-9277ANDA
Acitretin	Acitretin	capsule, oral	0093-1135ANDA
-	Acitretin	capsule	0093-1136DRUG FOR FURTHER PROCESSING
Acitretin	Acitretin	capsule, oral	0093-1138ANDA
Acyclovir	acyclovir	cream, topical	0093-3630NDA AUTHORIZED GENERIC
Adalimumab-ryvk	adalimumab-ryvk	kit	51759-310BLA
Adalimumab-ryvk	adalimumab-ryvk	kit	51759-311BLA
Adalimumab-ryvk	adalimumab-ryvk	kit	51759-360BLA
Adalimumab-ryvk	adalimumab-ryvk	kit	51759-361BLA
Adapalene and benzoyl peroxide	Adapalene and benzoyl peroxide	gel, topical	0480-3154ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-105ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-110ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-112ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-115ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-117ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-120ANDA
Adderall	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate	tablet, oral	57844-130ANDA
Albuterol Sulfate HFA	Albuterol Sulfate	aerosol, metered, respiratory (inhalation)	0093-3174NDA AUTHORIZED GENERIC
Almotriptan Malate	Almotriptan Malate	tablet, film coated, oral	0093-5260ANDA
Almotriptan Malate	Almotriptan Malate	tablet, film coated, oral	0093-5261ANDA
Amethyst	Levonorgestrel and Ethinyl Estradiol	tablet, oral	0480-3472ANDA
Amiloride Hydrochloride and Hydrochlorothiazide	Amiloride Hydrochloride and Hydrochlorothiazide	tablet, oral	0555-0483ANDA
Amlodipine Besylate	Amlodipine Besylate	tablet, oral	0480-0083ANDA
Amlodipine Besylate	Amlodipine Besylate	tablet, oral	0480-7167ANDA
Amlodipine Besylate	Amlodipine Besylate	tablet, oral	0480-7168ANDA
Amoxicillin	Amoxicillin	tablet, film coated, oral	0093-2263ANDA
Amoxicillin	Amoxicillin	tablet, film coated, oral	0093-2264ANDA
Amoxicillin	Amoxicillin	tablet, chewable, oral	0093-2267ANDA
Amoxicillin	Amoxicillin	tablet, chewable, oral	0093-2268ANDA
Amoxicillin	Amoxicillin	capsule, oral	0093-3107ANDA
Amoxicillin	Amoxicillin	capsule, oral	0093-3109ANDA
Amoxicillin	Amoxicillin	powder, for suspension, oral	0093-4155ANDA
Amoxicillin	Amoxicillin	powder, for suspension, oral	0093-4160ANDA
Amoxicillin	Amoxicillin	powder, for suspension, oral	0093-4161ANDA
Amoxicillin and Clavulanate Potassium	Amoxicillin and Clavulanate Potassium	tablet, film coated, oral	0093-2274ANDA
Amoxicillin and Clavulanate Potassium	Amoxicillin and Clavulanate Potassium	tablet, film coated, oral	0093-2275ANDA
Amoxicillin and Clavulanate Potassium	Amoxicillin and Clavulanate Potassium	powder, for suspension, oral	0093-2277ANDA
Amoxicillin and Clavulanate Potassium	Amoxicillin and Clavulanate Potassium	powder, for suspension, oral	0093-2279ANDA
Amoxicillin and Clavulanate Potassium	Amoxicillin and Clavulanate Potassium	powder, for suspension, oral	0093-8675ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3315ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3316ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3317ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3318ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3319ANDA
Amphetamine	Amphetamine	tablet, orally disintegrating, oral	0480-3320ANDA
Anastrozole	Anastrozole	tablet, film coated, oral	0093-7536ANDA
Apri 28 Day	Desogestrel and Ethinyl Estradiol	kit	0555-9043ANDA
Aranelle	norethindrone and ethinyl estradiol	kit	0555-9066ANDA
Armodafinil	Armodafinil	tablet, oral	0093-3090NDA AUTHORIZED GENERIC
Armodafinil	Armodafinil	tablet, oral	0093-3092NDA AUTHORIZED GENERIC
Armodafinil	Armodafinil	tablet, oral	0093-3094NDA AUTHORIZED GENERIC
Atazanavir Sulfate	Atazanavir Sulfate	capsule, oral	0093-5526ANDA
Atazanavir Sulfate	Atazanavir Sulfate	capsule, oral	0093-5527ANDA
Atazanavir Sulfate	Atazanavir Sulfate	capsule, oral	0093-5528ANDA
Atenolol	Atenolol	tablet, oral	0093-0752ANDA
Atenolol	Atenolol	tablet, oral	0093-0753ANDA
Atenolol	Atenolol	tablet, oral	0093-0787ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3542ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3543ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3544ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3545ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3546ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3547ANDA
Atomoxetine	Atomoxetine	capsule, oral	0093-3548ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0093-5056ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0093-5057ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0093-5058ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0093-5059ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0480-3585ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0480-3586ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0480-3587ANDA
Atorvastatin Calcium	Atorvastatin Calcium	tablet, film coated, oral	0480-3588ANDA
Aviane	Levonorgestrel and Ethinyl Estradiol	kit	0555-9045ANDA
Azelastine Hydrochloride and Fluticasone Propionate	Azelastine Hydrochloride and Fluticasone Propionate	spray, metered, nasal	0480-2157ANDA
Azithromycin	Azithromycin	powder, for suspension, oral	0093-2026ANDA
Azithromycin	Azithromycin	powder, for suspension, oral	0093-2027ANDA
Azithromycin	Azithromycin	tablet, film coated, oral	50111-787ANDA
Azithromycin	Azithromycin	tablet, film coated, oral	50111-788ANDA
Azithromycin	Azithromycin	tablet, film coated, oral	50111-789ANDA
Baclofen	Baclofen	tablet, oral	0172-4096ANDA
Baclofen	Baclofen	tablet, oral	0172-4097ANDA
Balziva	Norethindrone and Ethinyl Estradiol	kit	0555-9034ANDA
Bendeka	bendamustine hydrochloride	injection, solution, intravenous	63459-348NDA
Budesonide	Budesonide	suspension, respiratory (inhalation)	0093-6815ANDA
Budesonide	Budesonide	suspension, respiratory (inhalation)	0093-6816ANDA
Budesonide	Budesonide	suspension, respiratory (inhalation)	0093-6817ANDA
Budesonide and formoterol fumarate dihydrate	Budesonide and formoterol fumarate dihydrate	aerosol, metered, respiratory (inhalation)	0480-3080ANDA
Budesonide and formoterol fumarate dihydrate	Budesonide and formoterol fumarate dihydrate	aerosol, metered, respiratory (inhalation)	0480-3081ANDA
Buprenorphine	Buprenorphine	patch, extended release, transdermal	0093-3239ANDA
Buprenorphine	Buprenorphine	patch, extended release, transdermal	0093-3656ANDA
Buprenorphine	Buprenorphine	patch, extended release, transdermal	0093-3657ANDA
Buprenorphine	Buprenorphine	patch, extended release, transdermal	0093-3658ANDA
Buprenorphine	Buprenorphine	patch, extended release, transdermal	0093-3659ANDA
Buspirone Hydrochloride	Buspirone Hydrochloride	tablet, oral	0093-0053ANDA
Buspirone Hydrochloride	Buspirone Hydrochloride	tablet, oral	0093-0054ANDA
Buspirone Hydrochloride	Buspirone Hydrochloride	tablet, oral	0093-1003ANDA
Buspirone Hydrochloride	Buspirone Hydrochloride	tablet, oral	0093-5200ANDA
Cabergoline	Cabergoline	tablet, oral	0093-5420ANDA
Calcitriol	Calcitriol	capsule, liquid filled, oral	0093-7352ANDA
Calcitriol	Calcitriol	capsule, liquid filled, oral	0093-7353ANDA
Camrese	Levonorgestrel / Ethinyl Estradiol and Ethinyl Estradiol	kit	0093-3134NDA AUTHORIZED GENERIC
Capecitabine	Capecitabine	tablet, film coated, oral	0093-7473ANDA
Capecitabine	Capecitabine	tablet, film coated, oral	0093-7474ANDA
Carbidopa and levodopa	Carbidopa and levodopa	tablet, oral	0093-9701ANDA
Carbidopa and levodopa	Carbidopa and levodopa	tablet, oral	0093-9702ANDA
Carbidopa and levodopa	Carbidopa and levodopa	tablet, oral	0093-9703ANDA
Carvedilol	Carvedilol	tablet, film coated, oral	0093-0051ANDA
Carvedilol	Carvedilol	tablet, film coated, oral	0093-0135ANDA
Carvedilol	Carvedilol	tablet, film coated, oral	0093-7295ANDA
Carvedilol	Carvedilol	tablet, film coated, oral	0093-7296ANDA
Cefaclor	Cefaclor	tablet, film coated, extended release, oral	0093-1087ANDA
Cefadroxil	Cefadroxil	capsule, oral	0093-3196ANDA
Cefadroxil	Cefadroxil	tablet, oral	0093-4059ANDA
Cefdinir	Cefdinir	capsule, oral	0093-3160ANDA
Cefdinir	Cefdinir	powder, for suspension, oral	0093-4136ANDA
Cefdinir	Cefdinir	powder, for suspension, oral	0093-4137ANDA
Cefprozil	Cefprozil	tablet, film coated, oral	0093-1077ANDA
Cefprozil	Cefprozil	tablet, film coated, oral	0093-1078ANDA
Cephalexin	Cephalexin	tablet, oral	0093-2238ANDA
Cephalexin	Cephalexin	tablet, oral	0093-2240ANDA
Cephalexin	Cephalexin	capsule, oral	0093-3145ANDA
Cephalexin	Cephalexin	capsule, oral	0093-3147ANDA
Cephalexin	Cephalexin	powder, for suspension, oral	0093-4175ANDA
Cephalexin	Cephalexin	powder, for suspension, oral	0093-4177ANDA
Chlordiazepoxide Hydrochloride	Chlordiazepoxide Hydrochloride	capsule, oral	0555-0033ANDA
Chlordiazepoxide Hydrochloride	Chlordiazepoxide Hydrochloride	capsule, oral	0555-0158ANDA
Chlordiazepoxide Hydrochloride	Chlordiazepoxide Hydrochloride	capsule, oral	0555-0159ANDA
Cilostazol	Cilostazol	tablet, oral	0093-2064ANDA
Cilostazol	Cilostazol	tablet, oral	0093-2065ANDA
-	Cimetidine	tablet, film coated	0093-8192DRUG FOR FURTHER PROCESSING
-	Cimetidine	tablet, film coated	0093-8204DRUG FOR FURTHER PROCESSING
Cimetidine	Cimetidine	tablet, film coated, oral	0093-8305ANDA
-	Ciprofloxacin	tablet, film coated	16252-514DRUG FOR FURTHER PROCESSING
Ciprofloxacin	Ciprofloxacin	tablet, film coated, oral	16252-515ANDA
Claravis	Isotretinoin	capsule, liquid filled, oral	0555-1054ANDA
Claravis	Isotretinoin	capsule, liquid filled, oral	0555-1055ANDA
Claravis	Isotretinoin	capsule, liquid filled, oral	0555-1056ANDA
Claravis	Isotretinoin	capsule, liquid filled, oral	0555-1057ANDA
Clonazepam	Clonazepam	tablet, oral	0093-0832ANDA
Clonazepam	Clonazepam	tablet, oral	0093-3212ANDA
Clonazepam	Clonazepam	tablet, oral	0093-3213ANDA
Clonazepam	Clonazepam	tablet, orally disintegrating, oral	0093-9290ANDA
Clonazepam	Clonazepam	tablet, orally disintegrating, oral	0093-9291ANDA
Clonazepam	Clonazepam	tablet, orally disintegrating, oral	0093-9292ANDA

Neighbours

Registered in the same town

SGS North America Inc.Fairfield, NJ; Markham, CAN · 2 sites
API Solutions Inc.Fairfield, NJ
GBA Pharma GmbHUlm, DEU
Mondelez Global LLCScarborough, CAN
Aarkish Pharmaceuticals NJ IncFairfield, NJ
Akron Pharma Inc.Fairfield, NJ
GRANULATION TECHNOLOGY, INC.FAIRFIELD, NJ
Garonit Pharmaceutical, Inc.Fairfield, NJ
Leading Pharma, LLCFairfield, NJ

Compare

Comparable companies in Canada

Apotex Inc.6 sites · 372 NDC
Laboratoires Abbott CIE3 sites · 1 NDC
Contract Pharmaceuticals Limited Canada3 sites · 0 NDC
9305-6828 Quebec Inc2 sites · 33 NDC
Laboratoire Atlas Inc2 sites · 8 NDC
BWXT Medical Ltd.2 sites · 6 NDC
Deciem Inc2 sites · 3 NDC
Canada Packers Inc.2 sites · 2 NDC
BioVectra Inc.2 sites · 1 NDC
Resilience Biotechnologies Inc.2 sites · 1 NDC

Enquiry

Common questions

Is Teva Pharmaceutical Industries Ltd. FDA approved?: Teva Pharmaceutical Industries Ltd. holds 6 FDA-registered establishments across 4 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Teva Pharmaceutical Industries Ltd.'s drugs manufactured?: At registered sites in Canada, Germany, Israel, the United States. The FDA register lists Markham; Scarborough; Stouffville; Ulm; Kfar Saba; Fairfield, NJ. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, sterilize.
What drugs does Teva Pharmaceutical Industries Ltd. make?: 668 products are listed under Teva Pharmaceutical Industries Ltd. in the openFDA NDC Directory, most often as tablet, film coated; tablet; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Teva Pharmaceutical Industries Ltd. products in shortage?: 44 presentations are currently listed in the FDA drug shortage database under Teva Pharmaceutical Industries Ltd., covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet, Azacitidine Injection, Carboplatin Injection and 7 other drugs.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.